PharmaShots | Incisive News in 3 Shots

Subscribe Now

MACE events

Regeneron and Sanofi Reports Results of Praluent (alirocumab) in ODYSSEY OUTCOMES study in Patients with MACE events- Presented at AHA 2018

Regeneron and Sanofi Reports Results of Praluent (alirocumab) in ODYSSEY OUTCOMES study in Patients with MACE events- Presented at...

November 12, 2018

Janssen's (J&J) Invokana (canagliflozin) Receives FDA Approval for MACE events in Adults with T2D

Janssen's (J&J) Invokana (canagliflozin) Receives FDA Approval for MACE events in Adults with T2D

October 31, 2018

Contact Us

First Floor, B-66, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
connect@pharmashots.com
Newsletter

Our Information

Follow Us